Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRASTUZUMAB Cause Electrocardiogram repolarisation abnormality? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Electrocardiogram repolarisation abnormality have been filed in association with TRASTUZUMAB (Trazimera). This represents 0.0% of all adverse event reports for TRASTUZUMAB.

5
Reports of Electrocardiogram repolarisation abnormality with TRASTUZUMAB
0.0%
of all TRASTUZUMAB reports
0
Deaths
1
Hospitalizations

How Dangerous Is Electrocardiogram repolarisation abnormality From TRASTUZUMAB?

Of the 5 reports, 1 (20.0%) required hospitalization.

Is Electrocardiogram repolarisation abnormality Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does TRASTUZUMAB Cause?

Diarrhoea (4,996) Off label use (3,802) Nausea (3,499) Fatigue (3,417) Myelosuppression (2,552) Disease progression (2,449) Death (2,378) Vomiting (2,244) Dyspnoea (2,010) Pyrexia (1,886)

What Other Drugs Cause Electrocardiogram repolarisation abnormality?

CLOZAPINE (25) QUETIAPINE (23) SERTRALINE (20) ALCOHOL (17) DIGOXIN (17) PROPOFOL (16) RIBOCICLIB (16) ALPRAZOLAM (15) ARIPIPRAZOLE (15) LEVETIRACETAM (15)

Which TRASTUZUMAB Alternatives Have Lower Electrocardiogram repolarisation abnormality Risk?

TRASTUZUMAB vs TRASTUZUMAB-ANNS TRASTUZUMAB vs TRASTUZUMAB DERUXTECAN TRASTUZUMAB vs TRASTUZUMAB-DKST TRASTUZUMAB vs TRASTUZUMAB-DTTB TRASTUZUMAB vs TRASTUZUMAB EMTANSINE

Related Pages

TRASTUZUMAB Full Profile All Electrocardiogram repolarisation abnormality Reports All Drugs Causing Electrocardiogram repolarisation abnormality TRASTUZUMAB Demographics